Internal Medicine, Rheumatology · Lancaster, PA
NPI
1194706143
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2108 Harrisburg Pike, Suite 200
Lancaster, PA, 17601
Phone (717) 299-1301
Groups this clinician bills Medicare through
Medicare paid, 2024
$628K
80,109 services
Medicare patients, 2024
1,224
Average age 75
Drug cost, 2024
$1.9M
3,739 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandhya K Adusumilli was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 44,000 times for 17 patients. In total Sandhya K Adusumilli billed 80,109 services in 33 codes, and Medicare paid $628K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 44,000 | 17 | $3.61 | $159K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 25,095 | 32 | $8.50 | $213K |
| J0897 Injection, denosumab, 1 mg | Office | 6,900 | 77 | $20.10 | $139K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,360 | 12 | $0.10 | $140 |
| 99214 Office E&M - Established | Office | 725 | 402 | $85.58 | $62K |
| 77080 Standard X-ray | Office | 721 | 721 | $8.89 | $6,412 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 427 | 326 | $12.38 | $5,286 |
| 96372 Injection Administration | Office | 264 | 111 | $10.63 | $2,807 |
| 99215 Office E&M - Established | Office | 120 | 89 | $117.19 | $14K |
| 99205 Office E&M - New | Office | 118 | 118 | $148.64 | $18K |
| 96401 Chemotherapy Administration | Office | 76 | 17 | $52.41 | $3,983 |
| 36415 Venipuncture Blood Collection | Office | 68 | 54 | $8.65 | $588 |
| 77081 Standard X-ray | Office | 63 | 63 | $8.91 | $562 |
| 85025 Blood Count | Office | 32 | 22 | $7.61 | $244 |
| 85652 Clinical Chemistry | Office | 26 | 24 | $2.57 | $66.74 |
By year: 2022 $672K for 89,551 services; 2023 $820K for 109,913 services; 2024 $628K for 80,109 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 68 | 54 | $8.65 | $588 |
| 85025 Blood Count | 32 | 22 | $7.61 | $244 |
| 85652 Clinical Chemistry | 26 | 24 | $2.57 | $66.74 |
| 82306 Clinical Chemistry | 15 | 15 | $29.01 | $435 |
Medicare prescription drug claims, 2024
In 2024, the drug Sandhya K Adusumilli prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,190 prescriptions and refills. In total Sandhya K Adusumilli wrote 3,739 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,190 | 2,247 | 258 | $41K |
| Methotrexate Methotrexate Sodium | 428 | 916 | 104 | $14K |
| Sulfasalazine Generic | 394 | 729 | 83 | $13K |
| Alendronate Sodium Generic | 312 | 623 | 90 | $1,885 |
| Prednisone Generic | 227 | 356 | 81 | $1,304 |
| Duloxetine Hcl Generic | 150 | 262 | 34 | $2,231 |
| Leflunomide Generic | 102 | 210 | 23 | $3,557 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 70 | 72 | 11 | $1,270 |
| Humira(Cf) Pen Adalimumab | 66 | 68 | 14 | $456K |
| Enbrel Sureclick Etanercept | 65 | 66 | Under 11 | $480K |
| Tramadol Hcl Generic | 63 | 64 | 13 | $282 |
| Tymlos Abaloparatide | 59 | 59 | Under 11 | $153K |
| Sulfasalazine Dr Sulfasalazine | 54 | 122 | 13 | $4,419 |
| Allopurinol Generic | 52 | 126 | 15 | $349 |
| Hydrochlorothiazide Generic | 37 | 57 | Under 11 | $150 |
Brand drugs: 674 claims; generic drugs: 2,963 claims; opioid claims: 67.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sandhya K Adusumilli were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.